| JYHB2002718 | 沙库巴曲缬沙坦钠片 | sacubitril;valsartan | Tablet | Chemical Drugs | Supplementary Application | 2020-12-30 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Review | 2022-01-27 | view |
| JYHB2100143 | 布林佐胺噻吗洛尔滴眼液 | brinzolamide;timolol maleate | Eye drops | Chemical Drugs | Supplementary Application | 2021-02-25 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Review | 2022-01-27 | view |
| JYHB2002720 | 沙库巴曲缬沙坦钠片 | sacubitril;valsartan | Tablet | Chemical Drugs | Supplementary Application | 2020-12-30 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Review | 2022-01-27 | view |
| JYHB2002717 | 沙库巴曲缬沙坦钠片 | sacubitril;valsartan | Tablet | Chemical Drugs | Supplementary Application | 2020-12-30 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Review | 2022-01-27 | view |
| JYHB2002716 | 沙库巴曲缬沙坦钠片 | sacubitril;valsartan | Tablet | Chemical Drugs | Supplementary Application | 2020-12-30 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Review | 2022-01-27 | view |
| JYHB2100144 | 布林佐胺滴眼液 | brinzolamide | Eye drops | Chemical Drugs | Supplementary Application | 2021-02-25 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Review | 2022-01-27 | view |
| CYHB2100067 | 缬沙坦胶囊 | valsartan | Capsule | Chemical Drugs | Supplementary Application | 2021-01-11 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Review | 2022-01-19 | view |
| CYHB2100068 | 缬沙坦胶囊 | valsartan | Capsule | Chemical Drugs | Supplementary Application | 2021-01-11 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Review | 2022-01-19 | view |
| JYHB2002592 | 盐酸倍他洛尔滴眼液 | betaxolol hydrochloride | Eye drops | Chemical Drugs | Supplementary Application | 2020-12-17 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Approval | 2021-12-29 | view |
| JXSS2000049 | 奥法妥木单抗注射液 | ofatumumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-11-05 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Approval Completed-Pending Certificated | 2021-12-20 | view |
| JYHB2000388 | 马来酸茚达特罗吸入粉雾剂 | indacaterol maleate | Powder for inhalation | Chemical Drugs | Supplementary Application | 2020-04-17 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-11-30 | view |
| JYHB2002754 | 磷酸芦可替尼片 | ruxolitinib phosphate | Tablet | Chemical Drugs | Supplementary Application | 2021-01-01 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Approval Completed-Pending Certificated | 2021-10-25 | view |
| JYHB2000621 | 甲磺酸达拉非尼胶囊 | dabrafenib mesylate | Capsule | Chemical Drugs | Supplementary Application | 2020-06-03 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-10-15 | view |
| JYHB2000620 | 甲磺酸达拉非尼胶囊 | dabrafenib mesylate | Capsule | Chemical Drugs | Supplementary Application | 2020-06-03 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-10-15 | view |
| CYHB1806195 | 氟伐他汀钠缓释片 | fluvastatin sodium | Tablet, extended release | Chemical Drugs | Supplementary Application | 2018-11-26 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-09-26 | view |
| CYHB1806194 | 氟伐他汀钠胶囊 | fluvastatin sodium | Capsule | Chemical Drugs | Supplementary Application | 2018-11-26 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-09-26 | view |
| JYHB2002066 | 茚达特罗格隆溴铵吸入粉雾剂用胶囊 | glycopyrronium bromide;indacaterol maleate | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2020-10-19 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-09-14 | view |
| JXSS2000045 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-08-17 | view |
| JXSS2000044 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-08-17 | view |
| JXSS2000047 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-08-17 | view |
